Tag: C reactive protein

Extensive clinical trials have shown that statins can significantly reduce C-reactive protein (CRP), a key marker of inflammation, by as much as 13% to 37% [1.3.4, 1.3.6, 1.5.5]. This raises the critical question: **Do statins reduce inflammation** independently of their cholesterol-lowering effects?

In a meta-analysis involving multiple clinical trials, naproxen was uniquely associated with a significant decrease in C-reactive protein (CRP) levels, distinguishing its effect from the broader class of nonsteroidal anti-inflammatory drugs (NSAIDs). This crucial finding directly answers the question: does naproxen affect CRP levels, and highlights the importance of considering specific drug properties in pharmacological analysis.

In a study of rheumatoid arthritis patients, those treated with hydroxychloroquine at a 400 mg/day dose were found to have significantly lower average CRP values compared to non-treated groups, which helps to answer the question: **Does hydroxychloroquine lower CRP**? The drug works gradually by modulating the immune system to reduce systemic inflammation.

Feeling symptomatically better is often the first sign of improvement, but emerging research shows that symptom relief alone isn't enough to ensure the underlying inflammation of Crohn's is controlled. Knowing **how do I know if my Crohn's medication is working?** involves a holistic approach that goes beyond just how you feel day-to-day.